+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cardiac Biomarkers - Global Market Trajectory & Analytics

  • ID: 834989
  • Report
  • May 2020
  • Region: Global
  • 177 Pages
  • Global Industry Analysts, Inc
1 of 2
Amid the COVID-19 crisis and the looming economic recession, the Cardiac Biomarkers market worldwide will grow by a projected US$4.5 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 8.1%. Laboratory Testing, one of the segments analyzed and sized in this study, is forecast to grow at over 7.7% and reach a market size of US$6.8 Billion by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Laboratory Testing market will be reset to a new normal which going forward in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 6.6% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$135.9 Million to the region's size over the next 7 to 8 years. In addition, over US$131.8 Million worth of projected demand in the region will come from Rest of the European markets. In Japan, the Laboratory Testing segment will reach a market size of US$315 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Cardiac Biomarkers market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 12.9% over the next couple of years and add approximately US$1.1 Billion in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Cardiac Biomarkers market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others:

Abbott Diagnostics, Beckman Coulter Inc, BG Medicine, bioMérieux SA, Boditech Med Inc, Labsystems Diagnostics OY, LifeSign LLC, LSI Medience Corp, Merck KGaA, Ortho-Clinical Diagnostics Inc, Quidel Corporation, Randox Laboratories, Response Biomedical Corp, Roche Diagnostics Corp, Siemens Healthineers
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
A Curtain Raiser
Major Cardiac Markers and their Properties
Recent Market Activity
Market Set to Record Strong Growth Led by Advancements in Cardiac Biomarker Combinations
North America Corners Biggest Slice, Asia-Pacific to Dictate Market Momentum
Laboratory Testing Remains Gold Standard, POC Testing Rapidly Gains Traction
Analysis by Type of Cardiac Biomarker Assay/Test
Competitive Landscape
Intense Competition among Players in the Cardiac Diagnostics Market
Leading Vendors Focus on Curtailing Turnaround Time of POC Cardiac Testing Kits
Cardiac Markers Point-Of-Care Testing (POC) Cardiac Testing Segment: Major Players and their Operating Brands
Other Recent Innovations
Lipid Biomarker Panel to Detect HfrEF
VectraplexECG System with CEB® Cardiac Electrical Biomarker
Cardiac Biomarkers on Smartphone
Stringent Regulations and Other Challenges
Global Competitor Market Shares
Cardiac Biomarkers Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
Abbott Diagnostics, Inc. (USA)
Quidel Corporation (USA)
Beckman Coulter, Inc. (USA)
BG Medicine, Inc. (USA)
biomérieux SA (France)
Boditech Med Inc. (South Korea)
Labsystems Diagnostics OY (Finland)
LifeSign LLC (USA)
LSI Medience Corporation (Japan)
Ortho-Clinical Diagnostics, Inc. (USA)
Randox Laboratories Ltd. (UK)
Response Biomedical Corp. (Canada)
Roche Diagnostics (Switzerland)
Siemens Healthineers (USA)
Merck KGaA (Germany)

3. MARKET TRENDS & DRIVERS
The Grim Reality of Mounting Economic and Social Burden of Cardiovascular Disease
Population Explosion, Ballooning Geriatric Populace, Longer Life Expectancy Contributing to Rising Tide of CVDs
Cardiac Biomarkers Hold the Key to Timely, Accurate Diagnosis & Prognosis
Commercialization of Novel Biomarkers to Drive Market Growth
Personalized Medicine, Companion Diagnostics Open Up Opportunities for Cardiac Biomarker Developers
Cardiac Biomarkers - A Powerful Tool for Patient Triaging
Cardiac Biomarkers Market Transitions from Mono-Marker to Multi-Marker Assays
Government Support Instrumental for Boosting Market Momentum
Secretoneurin Biomarker - a Potential Game Changer for Diagnosis of Cardiac Arrhythmias
High-Performance Techniques Drive Biomarker Discovery in Cardiology
Biomarkers for Acute Coronary Syndromes (ACS): A Leading Segment
Biomarkers - A Promising Diagnostic Tool for ACS
Biomarker Discovery for ACS to Undergo Significant Changes
Cardiac Biomarker Play Critical Role in Stroke Diagnosis
Cardiac Biomarkers to Find a Place in Neonatal Diagnosis and Treatment
Specificity, Sensitivity, Side Effects, Cost Concerns Hinder Market Growth

4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Cardiac Biomarkers Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
TABLE 2: Cardiac Biomarkers Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
TABLE 3: Cardiac Biomarkers Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: Laboratory Testing (Location Type) World Market by Region/Country in US$ Thousand: 2020 to 2027
TABLE 5: Laboratory Testing (Location Type) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
TABLE 6: Laboratory Testing (Location Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: Point-of-Care Testing (Location Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
TABLE 8: Point-of-Care Testing (Location Type) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
TABLE 9: Point-of-Care Testing (Location Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Cardiac Biomarkers Market Share (in %) by Company: 2020 & 2025
Market Analytics
TABLE 10: United States Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2020 to 2027
TABLE 11: Cardiac Biomarkers Market in the United States by Location Type: A Historic Review in US$ Thousand for 2012-2019
TABLE 12: United States Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
CANADA
TABLE 13: Canadian Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020 to 2027
TABLE 14: Canadian Cardiac Biomarkers Historic Market Review by Location Type in US$ Thousand: 2012-2019
TABLE 15: Cardiac Biomarkers Market in Canada: Percentage Share Breakdown of Sales by Location Type for 2012, 2020, and 2027
JAPAN
TABLE 16: Japanese Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2020-2027
TABLE 17: Cardiac Biomarkers Market in Japan: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2012-2019
TABLE 18: Japanese Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
CHINA
TABLE 19: Chinese Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2020-2027
TABLE 20: Cardiac Biomarkers Historic Market Analysis in China in US$ Thousand by Location Type: 2012-2019
TABLE 21: Chinese Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
EUROPE
Market Facts & Figures
European Cardiac Biomarkers Market: Competitor Market Share Scenario (in %) for 2020 & 2025
Market Analytics
TABLE 22: European Cardiac Biomarkers Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
TABLE 23: Cardiac Biomarkers Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
TABLE 24: European Cardiac Biomarkers Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 25: European Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020-2027
TABLE 26: Cardiac Biomarkers Market in Europe in US$ Thousand by Location Type: A Historic Review for the Period 2012-2019
TABLE 27: European Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
FRANCE
TABLE 28: Cardiac Biomarkers Market in France by Location Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 29: French Cardiac Biomarkers Historic Market Scenario in US$ Thousand by Location Type: 2012-2019
TABLE 30: French Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
GERMANY
TABLE 31: Cardiac Biomarkers Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
TABLE 32: German Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
TABLE 33: German Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
ITALY
TABLE 34: Italian Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2020-2027
TABLE 35: Cardiac Biomarkers Historic Market Analysis in Italy in US$ Thousand by Location Type: 2012-2019
TABLE 36: Italian Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED KINGDOM
TABLE 37: United Kingdom Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2020-2027
TABLE 38: Cardiac Biomarkers Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2012-2019
TABLE 39: United Kingdom Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
SPAIN
TABLE 40: Spanish Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020 to 2027
TABLE 41: Spanish Cardiac Biomarkers Historic Market Review by Location Type in US$ Thousand: 2012-2019
TABLE 42: Cardiac Biomarkers Market in Spain: Percentage Share Breakdown of Sales by Location Type for 2012, 2020, and 2027
RUSSIA
TABLE 43: Russian Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2020 to 2027
TABLE 44: Cardiac Biomarkers Market in Russia by Location Type: A Historic Review in US$ Thousand for 2012-2019
TABLE 45: Russian Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
REST OF EUROPE
TABLE 46: Rest of Europe Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020-2027
TABLE 47: Cardiac Biomarkers Market in Rest of Europe in US$ Thousand by Location Type: A Historic Review for the Period 2012-2019
TABLE 48: Rest of Europe Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
ASIA-PACIFIC
TABLE 49: Asia-Pacific Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
TABLE 50: Cardiac Biomarkers Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2012-2019
TABLE 51: Asia-Pacific Cardiac Biomarkers Market Share Analysis by Region/Country: 2012 VS 2020 VS 2027
TABLE 52: Cardiac Biomarkers Market in Asia-Pacific by Location Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 53: Asia-Pacific Cardiac Biomarkers Historic Market Scenario in US$ Thousand by Location Type: 2012-2019
TABLE 54: Asia-Pacific Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
AUSTRALIA
TABLE 55: Cardiac Biomarkers Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
TABLE 56: Australian Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
TABLE 57: Australian Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
INDIA
TABLE 58: Indian Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020 to 2027
TABLE 59: Indian Cardiac Biomarkers Historic Market Review by Location Type in US$ Thousand: 2012-2019
TABLE 60: Cardiac Biomarkers Market in India: Percentage Share Breakdown of Sales by Location Type for 2012, 2020, and 2027
SOUTH KOREA
TABLE 61: Cardiac Biomarkers Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
TABLE 62: South Korean Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
TABLE 63: Cardiac Biomarkers Market Share Distribution in South Korea by Location Type: 2012 VS 2020 VS 2027
REST OF ASIA-PACIFIC
TABLE 64: Rest of Asia-Pacific Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2020-2027
TABLE 65: Cardiac Biomarkers Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2012-2019
TABLE 66: Rest of Asia-Pacific Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
LATIN AMERICA
TABLE 67: Latin American Cardiac Biomarkers Market Trends by Region/Country in US$ Thousand: 2020-2027
TABLE 68: Cardiac Biomarkers Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2012-2019
TABLE 69: Latin American Cardiac Biomarkers Market Percentage Breakdown of Sales by Region/Country: 2012, 2020, and 2027
TABLE 70: Latin American Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2020-2027
TABLE 71: Cardiac Biomarkers Historic Market Analysis in Latin America in US$ Thousand by Location Type: 2012-2019
TABLE 72: Latin American Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
ARGENTINA
TABLE 73: Argentinean Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020-2027
TABLE 74: Cardiac Biomarkers Market in Argentina in US$ Thousand by Location Type: A Historic Review for the Period 2012-2019
TABLE 75: Argentinean Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
BRAZIL
TABLE 76: Cardiac Biomarkers Market in Brazil by Location Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 77: Brazilian Cardiac Biomarkers Historic Market Scenario in US$ Thousand by Location Type: 2012-2019
TABLE 78: Brazilian Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
MEXICO
TABLE 79: Cardiac Biomarkers Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
TABLE 80: Mexican Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
TABLE 81: Mexican Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
REST OF LATIN AMERICA
TABLE 82: Rest of Latin America Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2020 to 2027
TABLE 83: Cardiac Biomarkers Market in Rest of Latin America by Location Type: A Historic Review in US$ Thousand for 2012-2019
TABLE 84: Rest of Latin America Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
MIDDLE EAST
TABLE 85: The Middle East Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
TABLE 86: Cardiac Biomarkers Market in the Middle East by Region/Country in US$ Thousand: 2012-2019
TABLE 87: The Middle East Cardiac Biomarkers Market Share Breakdown by Region/Country: 2012, 2020, and 2027
TABLE 88: The Middle East Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020 to 2027
TABLE 89: The Middle East Cardiac Biomarkers Historic Market by Location Type in US$ Thousand: 2012-2019
TABLE 90: Cardiac Biomarkers Market in the Middle East: Percentage Share Breakdown of Sales by Location Type for 2012,2020, and 2027
IRAN
TABLE 91: Iranian Market for Cardiac Biomarkers: Annual Sales Estimates and Projections in US$ Thousand by Location Type for the Period 2020-2027
TABLE 92: Cardiac Biomarkers Market in Iran: Historic Sales Analysis in US$ Thousand by Location Type for the Period 2012-2019
TABLE 93: Iranian Cardiac Biomarkers Market Share Analysis by Location Type: 2012 VS 2020 VS 2027
ISRAEL
TABLE 94: Israeli Cardiac Biomarkers Market Estimates and Forecasts in US$ Thousand by Location Type: 2020-2027
TABLE 95: Cardiac Biomarkers Market in Israel in US$ Thousand by Location Type: A Historic Review for the Period 2012-2019
TABLE 96: Israeli Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
SAUDI ARABIA
TABLE 97: Saudi Arabian Cardiac Biomarkers Market Growth Prospects in US$ Thousand by Location Type for the Period 2020-2027
TABLE 98: Cardiac Biomarkers Historic Market Analysis in Saudi Arabia in US$ Thousand by Location Type: 2012-2019
TABLE 99: Saudi Arabian Cardiac Biomarkers Market by Location Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
UNITED ARAB EMIRATES
TABLE 100: Cardiac Biomarkers Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
TABLE 101: United Arab Emirates Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
TABLE 102: Cardiac Biomarkers Market Share Distribution in United Arab Emirates by Location Type: 2012 VS 2020 VS 2027
REST OF MIDDLE EAST
TABLE 103: Cardiac Biomarkers Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Location Type for the Period 2020-2027
TABLE 104: Rest of Middle East Cardiac Biomarkers Historic Market Analysis in US$ Thousand by Location Type: 2012-2019
TABLE 105: Rest of Middle East Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027
AFRICA
TABLE 106: African Cardiac Biomarkers Market Estimates and Projections in US$ Thousand by Location Type: 2020 to 2027
TABLE 107: Cardiac Biomarkers Market in Africa by Location Type: A Historic Review in US$ Thousand for 2012-2019
TABLE 108: African Cardiac Biomarkers Market Share Breakdown by Location Type: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 39
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll